CCND1 and neoplasm: Clinically, cyclin D1 expression is correlated with tumor size, invasion, metastasis and clinical stages, highlighting that cyclin D1 can be considered as a prognostic factor to evaluate patient prognosis, and cyclin D1 signaling can be targeted to treat human cancers [67].